A New York-based healthcare investment firm has announced that it has raised $1.86 billion in commitments for OrbiMed Royalty ...

Germany’s BioNTech has reported revenues for the second quarter 2025 of 260.8 million euros ($302 million), more than double ...

Swedish biotech Hansa Biopharma on Friday released encouraging top-line results from three patients with Duchenne muscular ...

The US Food and Drug Administration (FDA) has approved a label update for Swiss pharma giant Novartis’ Leqvio (inclisiran), ...

Philadelphia, USA-based Medicus Pharma and Boston-based biotech Helix Nanotechnologies have entered into a non-binding ...

Chinese biotech Mabgeek Biotechnology has filed to go public in Hong Kong, seeking to raise funds to support development of ...

Biosimilars, once met with skepticism, are now an undeniable force in the global pharmaceutical market. As several ...

Findings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla (donanemab-azbt) continued to demonstrate ...

Allogene Therapeutics, a US biotech developing allogeneic CAR T products for cancer and autoimmune disease, closed 12% lower ...

Founded by experts in psychiatry and neuroscience to target neural circuits causally linked to disease, the company employs ...

A clinical‑stage biotech company developing gene therapies to treat common joint diseases such as knee osteoarthritis, which ...

A Seoul-based biotech company, founded to develop innovative therapies for neurodegenerative and immune disorders.